News

In the past couple years, demand has gone wild for drugs like Ozempic – and its cousins, Zepbound, Wegovy, and Mounjaro. For ...
Lilly's obesity pill orforglipron disappointed with lower weight loss, but its broad late-stage pipeline keeps growth hopes ...
A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) has been a trailblazer in the GLP-1 drug ...
Serena Williams, the tennis icon, has revealed her postpartum weight loss journey, shedding 31 pounds with the help of GLP-1 ...
Tennis legend Serena Williams reveals how she lost 14 kg by combining weight loss drugs with exercise and diet sharing a ...
American tennis legend Serena Williams revealed taking the help of GLP-1 drugs to attain an ideal figure after struggling to ...
Serena Williams, one of the most successful athletes of all time, has spoken out about using weight loss drugs - she says, to ...
In the world of fat activism, the “O-words” – overweight and obesity – are expressly verboten. That’s because advocates and ...
Serena Williams' revelation on Thursday that she'd lost 31 pounds came with another confession. Fans were angered with ...
Serena Williams has left fans concerned after she revealed a dramatic new-look following her major weight loss. The ...
The people of Northern Gaza are starving. That’s according to an official declaration by a United Nations-backed group of ...
Through innovation, cost discipline, legal action, and competitive pricing, Novo Nordisk has reasserted its leadership in the GLP-1 market. With a robust pipeline and global expansion, NVO is poised ...